Le Lézard
Classified in: Health
Subject: AWD

Ontario Hospitals Awarded for Maximizing the Gift of Life


Trillium Gift of Life Network announces 2016/17 hospital award recipients

TORONTO, Dec. 13, 2017 /CNW/ - Trillium Gift of Life Network is proud to present a record 36 awards to 29 hospitals and partners for their outstanding work in organ and tissue donation over the last fiscal year (April 1, 2016 ? March 31, 2017).

These remarkable hospitals and partners are being recognized across four categories (see below for the complete list of award recipients). Highlights include:

"Ontario has had three consecutive record years of lives saved through transplantation, and such success would not be possible without our dedicated partners," said Ronnie Gavsie, President and CEO, Trillium Gift of Life Network. "The achievement awards reflect how hospitals have embraced and integrated donation into quality end-of-life care."

"These achievement awards represent the hard work and commitment of our Ontario hospitals to save and enhance lives through organ and tissue donation," said Dr. Eric Hoskins, Ontario's Minister of Health and Long Term Care. "On behalf of the 1,500 people in Ontario currently waiting for a life-saving transplant, we applaud your dedication and we thank you."

2016/17 Hospital Award Recipients:

Trillium Gift of Life Network is a not-for-profit agency of the Government of Ontario responsible for planning, promoting, coordinating and supporting organ and tissue donation for transplantation across Ontario and improving the system so that more lives can be saved.

SOURCE Trillium Gift of Life Network


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: